======= PLA2G15 =======
== Gene Information ==
* **Official Symbol**: PLA2G15
* **Official Name**: phospholipase A2 group XV
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23659|23659]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q8NCC3|Q8NCC3]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PLA2G15&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLA2G15|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609362|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Has transacylase and calcium-independent phospholipase A2 activity (PubMed:20410020, PubMed:23958596). Catalyzes the formation of 1-O-acyl-N-acetylsphingosine and the concomitant release of a lyso-phospholipid (PubMed:11790796, PubMed:25727495). Has high activity with 1-palmitoyl-2-oleoyl-sn-glycero-3- phosphocholine (POPC) and 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), catalyzing the transfer of oleic acid to N-acetyl- sphingosine. Required for normal phospholipid degradation in alveolar and peritoneal macrophages and in spleen (By similarity). May have weak lysophospholipase activity (PubMed:10092508). {ECO:0000250|UniProtKB:Q8VEB4, ECO:0000269|PubMed:10092508, ECO:0000269|PubMed:11790796, ECO:0000269|PubMed:20410020, ECO:0000269|PubMed:23958596, ECO:0000269|PubMed:25727495}.
|Abhydrolase 6|
|LACT|
|phosphatidylethanolamine catabolic process|
|phosphatidylcholine catabolic process|
|calcium-independent phospholipase A2 activity|
|O-acyltransferase activity|
|glycerophospholipid catabolic process|
|lysophospholipase activity|
|phosphatidylethanolamine metabolic process|
|phospholipid catabolic process|
|glycerolipid catabolic process|
|phosphatidylcholine metabolic process|
|ceramide metabolic process|
|fatty acid catabolic process|
|phospholipid binding|
|monocarboxylic acid catabolic process|
|organophosphate catabolic process|
|sphingolipid metabolic process|
|ammonium ion metabolic process|
|cellular lipid catabolic process|
|membrane lipid metabolic process|
|lysosome|
|organic acid catabolic process|
|carboxylic acid catabolic process|
|lipid catabolic process|
|glycerophospholipid metabolic process|
|fatty acid metabolic process|
|phospholipid metabolic process|
|glycerolipid metabolic process|
|small molecule catabolic process|
|monocarboxylic acid metabolic process|
|intracellular membrane-bounded organelle|
|cellular amide metabolic process|
|organophosphate metabolic process|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxoacid metabolic process|
|organic acid metabolic process|
|organonitrogen compound catabolic process|
|lipid metabolic process|
|extracellular space|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|extracellular region|
|membrane|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp246|UM0011500 10μM R05 exp246]]|-3.52|
|[[:results:exp245|UM0011500 5μM R05 exp245]]|-2.46|
|[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-1.71|
|[[:results:exp52|Ribavirin 10μM R01 exp52]]|1.75|
|[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.76|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 14713
* **Expression level (log2 read counts)**: 4.3
{{:chemogenomics:nalm6 dist.png?nolink |}}